Effect of methadone treatment on incarceration rates among injection drug users

European Addiction Research

Volumn 14, Issue 3, 2008, Pages 143-149

  Werb, Daniel ^a   Kerr, Thomas ^a,b   Marsh, David ^c   Li, Kathy ^a   Montaner, Julio ^a,b   Wood, Evan ^a,b,d  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c VANCOUVER COASTAL HEALTH   (Canada)

^d BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

Author keywords

Generalized estimating equation method; Incarceration rates; Injection drug users; Methadone maintenance treatment; Vancouver Injection Drug Users Study (VIDUS)

Indexed keywords

METHADONE;

ADULT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DETENTION; DRUG EFFECT; FEMALE; HEROIN DEPENDENCE; HUMAN; INTRAVENOUS DRUG ABUSE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PRIORITY JOURNAL; PRISONER;

ADULT; AGE FACTORS; FEMALE; FOLLOW-UP STUDIES; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; INCIDENCE; INJECTIONS, INTRAVENOUS; MALE; METHADONE; NARCOTICS; PREVALENCE; PRISONERS;

EID: 45249089879     PISSN: 10226877     EISSN: None     Source Type: Journal    
DOI: 10.1159/000130418     Document Type: Article

References (45)

1. Drucker E: Drug prohibition and public health: 25 years of evidence. Public Health Rep 1999;114:14-29.
2. Knutsson J: Swedish drug markets and drugs policy;in Hough M, Natarajan M (eds): Illegal Drug Markets: From Research to Policy. Monsey/NJ, Criminal Justice Press, 2000, pp 179-202.
3. Maher L, Dixon D: Policing and public health: law enforcement and harm minimization in a street-level drug market. Br J Criminol 1999;39: 488-512.
4. Wodak A: Drug laws: war on drugs does more harm than good. BMJ 2001;323:866.
5. DeBeck K, Wood E, Montaner J, Kerr T: Canada's 2003 renewed drug strategy - an evidence-based review. HIV/AIDS Policy Law Rev 2007;11:1-9.
6. Kerr T, Wodak A, Elliott R, Montaner JS, Wood E: Opioid substitution and HIV/AIDS treatment and prevention. Lancet 2004;364:1918-1919.
7. Ball AL, Rana S, Dehne KL: HIV prevention among injecting drug users: responses in developing and transitional countries. Public Health Rep 1998;113(suppl 1):170-181.
8. Wolfe D, Malinowska-Sempruch K: Illicit Drug Policies and the Global HIV Epidemic: Effects of UN and National Government Approaches. New York, Open Society Institute, 2004.
9. Bach PB, Lantos J: Methadone dosing, heroin affordability, and the severity of addiction. Am J Public Health 1999;89:662-665.
10. Barnett PG: The cost-effectiveness of methadone maintenance as a health care intervention. Addiction 1999;94:479-488.
11. Cartwright WS: Cost-benefit analysis of drug treatment services: review of the literature. J Ment Health Policy Econ 2000;3:11-26.
12. Kerr T, Small W, Wood E: The public health and social impacts of drug market enforcement: a review of the evidence. Int J Drug Policy 2005;16:210-220.
13. Rydell CP, Caulkins JP, Everingham SE: Enforcement or treatment? Modeling the relative efficacy of alternatives for controlling cocaine. Oper Res 1996;44:687-695.
14. Wall R, Rehm J, Fischer B, Brands B, Gliksman L, Stewart J, et al: Social costs of untreated opioid dependence. J Urban Health 2000;77:688-722.
15. Friedman SR, Cooper HL, Tempalski B, Keem B, Friedman R, Flom PL, et al: Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS 2006;20:93-99.
16. Annitto WJ, Kelly C, Sees KL, Delucchi KL, Masson C, Rosen A, et al: Methadone maintenance for opioid dependence. JAMA 2000;284:694-695.
17. Bell J, Zador D: A risk-benefit analysis of methadone maintenance treatment. Drug Saf 2000;22:179-190.
18. Bertschy G: Methadone maintenance treatment: an update. Eur Arch Psychiatry Clin Neurosci 1995;245:114-124.
19. Borg L, Broe DM, Ho A, Kreek MJ: Cocaine abuse sharply reduced in an effective methadone maintenance program. J Addict Dis 1999;18:63-75.
20. Brands B, Blake J, Marsh D: Changing patient characteristics with increased methadone maintenance availability. Drug Alcohol Depend 2002;66:11-20.
21. Gronbladh L, Gunne L: Methadone-assisted rehabilitation of Swedish heroin addicts. Drug Alcohol Depend 1989;24:31-37.
22. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. JAMA 1998;280:1936-1943.
23. Wong KH, Lee SS, Lim WL, Low HK: Adherence to methadone is associated with a lower level of HIV-related risk behaviors in drug users. J Subst Abuse Treat 2003;24:233-239.
24. Dolan KA, Shearer J, MacDonald M, Mattick RP, Hall W, Wodak AD: A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. Drug Alcohol Depend 2003;72:59-65.
25. Small W, Kain S, Laliberte N, Schechter MT, O'Shaughnessy MV, Spittal PM: Incarceration, addiction and harm reduction: Inmates experience injecting drugs in prison. Subst Use Misuse 2005;40:831-843.
26. Wood E, Li K, Small W, Montaner JS, Schechter MT, Kerr T: Recent incarceration independently associated with syringe sharing by injection drug users. Public Health Rep 2005;120:150-156.
27. Tyndall MW, Currie S, Spittal P, Li K, Wood E, O'Shaughnessy MV, et al: Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 2003;17:887-893.
28. Kerr T, Palepu A, Barness G, Walsh J, Hogg R, Montaner J, et al: Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver. Antivir Ther 2004;9:407-414.
29. Liang KY, Zeger SL: Longitudinal data using generalized linear models. Biometrika 1986;73:13-22.
30. Zeger SL, Liang KY: Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-130.
31. Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, et al: Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help? CMAJ 2001;165:405-410.
32. Buavirat A, Page-Shafer K, van Griensven GJ, Mandel JS, Evans J, Chuaratanaphong J, et al: Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ 2003;326:308.
33. Clarke JG, Stein MD, Hanna L, Sobota M, Rich JD: Active and former injection drug users report of HIV risk behaviors during periods of incarceration. Subst Abus 2001;22:209-216.
34. Estebanez P, Zunzunegui MV, Aguilar MD, Russell N, Cifuentes I, Hankins C: The role of prisons in the HIV epidemic among female injecting drug users. AIDS Care 2002;14:95-104.
35. Ball J, Ross A: The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services and Outcomes. New York, Springer, 1991.
36. Fischer B, Gliksman L, Rehm J, Daniel N, Medved W: Comparing opiate users in methadone treatment with untreated opiate users: results of a follow-up study with a Toronto opiate user cohort. Can J Public Health 1999;90:299-303.
37. Rosenbaum M, Washburn A, Knight K, Kelley M, Irwin J: Treatment as harm reduction, defunding as harm maximization: the case of methadone maintenance. J Psychoactive Drugs 1996;28:241-249.
38. Sheerin I, Green T, Sellman D, Adamson S, Deering D: Reduction in crime by drug users on a methadone maintenance therapy programme in New Zealand. N Z Med J 2004;117:U795.
39. Rahbar AR, Rooholamini S, Khoshnood K: Prevalence of HIV infection and other blood-borne infections in incarcerated and non-incarcerated injection drug users in Mashhad, Iran. Int J Drug Policy 2004;15:151-155.
40. Jurgens R, Kerr T, Lines R, Stover H, Laticevschi D, Nelles J: Prison Needle Exchange: Lessons from a Comprehensive Review of International Evidence and Expertise. Toronto, Canadian HIV/AIDS Legal Network, 2006.
41. Dolan K, Rutter S, Wodak AD: Prison-based syringe exchange programmes: a review of international research and development. Addiction 2003;98:153-158.
42. Haslam P, Kaschube K, Hokayem MT, Barton J: Report on the Evaluation of Correctional Services of Canada's Methadone Maintenance Treatment Program. Ottawa, Correctional Services of Canada, 2004.
43. Sibbald B: Methadone maintenance expands inside federal prisons. CMAJ 2002;167:1154.
44. Statistics Canada: Adult Criminal Court Data Tables 1998/99. Ottawa, Canadian Centre for Justice Statistics, 2000.
45. Des Jarlais DC, Paone D, Milliken J, Turner CF, Miller H, Gribble J, et al: Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet 1999;353:1657-1661.